Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP607694.RAnFi30JC3J9Jyt-lp1msKzuUMuSH_aPdO2mzf4dR-N00130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP607694.RAnFi30JC3J9Jyt-lp1msKzuUMuSH_aPdO2mzf4dR-N00130_assertion type Assertion NP607694.RAnFi30JC3J9Jyt-lp1msKzuUMuSH_aPdO2mzf4dR-N00130_head.
- NP607694.RAnFi30JC3J9Jyt-lp1msKzuUMuSH_aPdO2mzf4dR-N00130_assertion description "[Therefore, the application of EGCG, PAI-1 silencing, and other emerging compounds tested using this model may provide effective treatment and potentially aid in the prevention of recurrence of KD following surgery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP607694.RAnFi30JC3J9Jyt-lp1msKzuUMuSH_aPdO2mzf4dR-N00130_provenance.
- NP607694.RAnFi30JC3J9Jyt-lp1msKzuUMuSH_aPdO2mzf4dR-N00130_assertion evidence source_evidence_literature NP607694.RAnFi30JC3J9Jyt-lp1msKzuUMuSH_aPdO2mzf4dR-N00130_provenance.
- NP607694.RAnFi30JC3J9Jyt-lp1msKzuUMuSH_aPdO2mzf4dR-N00130_assertion SIO_000772 23835737 NP607694.RAnFi30JC3J9Jyt-lp1msKzuUMuSH_aPdO2mzf4dR-N00130_provenance.
- NP607694.RAnFi30JC3J9Jyt-lp1msKzuUMuSH_aPdO2mzf4dR-N00130_assertion wasDerivedFrom befree-20150227 NP607694.RAnFi30JC3J9Jyt-lp1msKzuUMuSH_aPdO2mzf4dR-N00130_provenance.
- NP607694.RAnFi30JC3J9Jyt-lp1msKzuUMuSH_aPdO2mzf4dR-N00130_assertion wasGeneratedBy ECO_0000203 NP607694.RAnFi30JC3J9Jyt-lp1msKzuUMuSH_aPdO2mzf4dR-N00130_provenance.